ShareValue scores for YDES: Valuation 52, Quality 46, Growth 47, Health 48.
YDESNASDAQ
YD Bio Ltd
$2.36
(+5.07%)
YDESNASDAQ
YD Bio Ltd
$2.36(+5.07%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 16%
Rating
Trap Risk
Return
6% to 16%
Valuation
52
Fair Value
Price vs Value
Quality
46
Moderate
Business Strength
Growth
47
Moderate
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
13
Bearish
Price Trend
Company Details
About
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Market Cap$167M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1715
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026